TLR7/8-IN-1

CAS No. 2205095-75-4

TLR7/8-IN-1( —— )

Catalog No. M35003 CAS No. 2205095-75-4

TLR7/8-IN-1, a crystalline TLR7/TLR8 inhibitor from patent WO2019220390 (compound 2b), is a valuable compound for autoimmune disease research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 287 Get Quote
5MG 455 Get Quote
10MG 682 Get Quote
25MG 1122 Get Quote
50MG 1555 Get Quote
100MG 2043 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    TLR7/8-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    TLR7/8-IN-1, a crystalline TLR7/TLR8 inhibitor from patent WO2019220390 (compound 2b), is a valuable compound for autoimmune disease research.
  • Description
    TLR7/8-IN-1 is a crystalline from of a TLR7/TLR8 inhibitor extracted from patent WO2019220390, compound 2b. TLR7/8-IN-1 can be used for the research of autoimmune disease.
  • In Vitro
    TLR7/8-IN-1 is a crystalline from of a TLR7/TLR8 inhibitor. TLR7/8-IN-1 can be used for the research of autoimmune disease.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    TLR
  • Recptor
    TLR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2205095-75-4
  • Formula Weight
    532.68
  • Molecular Formula
    C29H40N8O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 12.5 mg/mL (23.47 mM; Ultrasonic )
  • SMILES
    Cc1nn(CC23CCC(CC2)(CC3)NC(=O)[C@@H]2COCCN2)c2CCN(Cc12)c1cc(C)nc2n(C)ncc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. WO2019220390
molnova catalog
related products
  • Imiquimod hydrochlor...

    Imiquimod hydrochloride (R 837 hydrochloride), a selective toll-like receptor 7 (TLR7) agonist, functions as an immune response modifier with in vivo antiviral and antitumor properties, and is utilized in researching external genital and perianal warts, cancer, and COVID-19 .

  • Loxoribine

    Loxoribine is a guanosine analog. Loxoribine is an orally bioavailable and selective Toll-like receptor (TLR) 7 agonist. It has anti-viral and anti-tumor activities.Loxoribine is a potent new immunostimulant with a relatively broad spectrum of immunobiological activities.

  • CU-CPT17e

    CU-CPT17e is a potent agonist of TLR(TLR3, TLR8, and TLR9).